Mining Public Toxicogenomic Data Reveals Insights and Challenges in Delineating Liver Steatosis Adverse Outcome Pathways

Genetic Liver-Specific AMPK Activation Protects against Diet-Induced Obesity and NAFLD

(2019) Daniel Garcia et al.   Cell Reports

Linking mitochondrial dysfunction to organismal and population health in context of environmental pollutants: Progress and considerations for mitochondrial adverse outcome pathways

(2019) David A. Dreier et al.   ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY

The transformics assay: first steps for the development of an integrated approach to investigate the malignant cell transformation in vitro

(2018) Maria Grazia Mascolo et al.   CARCINOGENESIS

Non-animal methods to predict skin sensitization (II): an assessment of defined approaches

(2018) Nicole C. Kleinstreuer et al.   CRITICAL REVIEWS IN TOXICOLOGY

QSAR modeling of ToxCast assays Relevant to the Molecular Initiating Events of AOPs Leading to Hepatic Steatosis

(2018) Domenico Gadaleta et al.   Journal of Chemical Information and Modeling

Comparative Proteomic Analysis of Liver Steatosis and Fibrosis after Oral Hepatotoxicant Administration in Sprague-Dawley Rats

(2018) B. Claire McDyre et al.   TOXICOLOGIC PATHOLOGY

Metabolic network-based predictions of toxicant-induced metabolite changes in the laboratory rat

(2018) Venkat R. Pannala et al.   Scientific Reports

Altered hepatic genes related to retinol metabolism and plasma retinol in patients with non-alcoholic fatty liver disease

(2018) Paulina Pettinelli et al.   PLoS One

Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

(2017) Zobair Younossi et al.   Nature Reviews Gastroenterology & Hepatology

The use of high-throughput screening techniques to evaluate mitochondrial toxicity

(2017) Lauren P. Wills   TOXICOLOGY

Reconciled rat and human metabolic networks for comparative toxicogenomics and biomarker predictions

(2017) Edik M. Blais et al.   Nature Communications

Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients

(2017) Franck Chiappini et al.   Scientific Reports

Nuclear receptors and nonalcoholic fatty liver disease 1 1This article is part of a Special Issue entitled: Xenobiotic nuclear receptors: New Tricks for An Old Dog, edited by Dr. Wen Xie.

(2016) Matthew C. Cave et al.   Biochimica et Biophysica Acta-Gene Regulatory Mechanisms

Mining kidney toxicogenomic data by using gene co-expression modules

(2016) Mohamed Diwan M. AbdulHameed et al.   BMC GENOMICS

Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis

(2016) Stefano Ballestri et al.   JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY

KEGG: new perspectives on genomes, pathways, diseases and drugs

(2016) Minoru Kanehisa et al.   NUCLEIC ACIDS RESEARCH

Tipping the Balance: Hepatotoxicity and the 4 Apical Key Events of Hepatic Steatosis

(2016) Michelle M. Angrish et al.   TOXICOLOGICAL SCIENCES

Moving Toward Integrating Gene Expression Profiling Into High-Throughput Testing: A Gene Expression Biomarker Accurately Predicts Estrogen Receptor α Modulation in a Microarray Compendium

(2016) Natalia Ryan et al.   TOXICOLOGICAL SCIENCES

Nonalcoholic fatty liver disease - A multisystem disease?

(2016) Ivana Mikolasevic et al.   WORLD JOURNAL OF GASTROENTEROLOGY

The identification of nuclear receptors associated with hepatic steatosis to develop and extend adverse outcome pathways

(2015) Claire L. Mellor et al.   CRITICAL REVIEWS IN TOXICOLOGY

Evidence of NAFLD progression from steatosis to fibrosing-steatohepatitis using paired biopsies: Implications for prognosis and clinical management

(2015) Stuart McPherson et al.   JOURNAL OF HEPATOLOGY

Farnesoid X nuclear receptor ligand obeticholic acid for non-cirrhotic, non-alcoholic steatohepatitis (FLINT): a multicentre, randomised, placebo-controlled trial

(2015) Brent A Neuschwander-Tetri et al.   LANCET

TRRUST: a reference database of human transcriptional regulatory interactions

(2015) Heonjong Han et al.   Scientific Reports

Role of NADPH oxidases in the redox biology of liver fibrosis

(2015) Eva Crosas-Molist et al.   Redox Biology

Mechanisms of amiodarone and valproic acid induced liver steatosis in mouse in vivo act as a template for other hepatotoxicity models

(2014) Alexa P. Vitins et al.   ARCHIVES OF TOXICOLOGY

A simple transcriptomic signature able to predict drug-induced hepatic steatosis

(2014) Marta Benet et al.   ARCHIVES OF TOXICOLOGY

FXR-dependent reduction of hepatic steatosis in a bile salt deficient mouse model

(2014) Cindy Kunne et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE

Open TG-GATEs: a large-scale toxicogenomics database

(2014) Yoshinobu Igarashi et al.   NUCLEIC ACIDS RESEARCH

Lipid Peroxidation: Production, Metabolism, and Signaling Mechanisms of Malondialdehyde and 4-Hydroxy-2-Nonenal

(2014) Antonio Ayala et al.   Oxidative Medicine and Cellular Longevity

Model Steatogenic Compounds (Amiodarone, Valproic Acid, and Tetracycline) Alter Lipid Metabolism by Different Mechanisms in Mouse Liver Slices

(2014) Ewa Szalowska et al.   PLoS One

A Meta Analysis of Pancreatic Microarray Datasets Yields New Targets as Cancer Genes and Biomarkers

(2014) Nalin C. W. Goonesekere et al.   PLoS One

Whole Genome Transcript Profiling of Drug Induced Steatosis in Rats Reveals a Gene Signature Predictive of Outcome

(2014) Nishika Sahini et al.   PLoS One

Systems Level Analysis and Identification of Pathways and Networks Associated with Liver Fibrosis

(2014) Mohamed Diwan M. AbdulHameed et al.   PLoS One

Identification of Environmental Chemicals Associated with the Development of Toxicant-associated Fatty Liver Disease in Rodents

(2014) Laila Al-Eryani et al.   TOXICOLOGIC PATHOLOGY

Clinical differences between alcoholic liver disease and nonalcoholic fatty liver disease

(2014) Nobuyuki Toshikuni   WORLD JOURNAL OF GASTROENTEROLOGY

The use of biomarkers of toxicity for integrating in vitro hazard estimates into risk assessment for humans

(2014) Bas Blaauboer   ALTEX-Alternatives to Animal Experimentation

Transforming growth factor beta signaling in hepatocytes participates in steatohepatitis through regulation of cell death and lipid metabolism in mice

(2013) Ling Yang et al.   HEPATOLOGY

Modulation of oxidative stress as an anticancer strategy

(2013) Chiara Gorrini et al.   NATURE REVIEWS DRUG DISCOVERY

Effect of Fasting on the Metabolic Response of Liver to Experimental Burn Injury

(2013) Mehmet A. Orman et al.   PLoS One

The relationship between oxidative stress and nonalcoholic fatty liver disease: Its effects on the development of nonalcoholic steatohepatitis

(2013) Fatma Ucar et al.   REDOX REPORT

The adverse outcome pathway concept: A pragmatic tool in toxicology

(2013) Mathieu Vinken   TOXICOLOGY

Aldehyde dehydrogenases in cellular responses to oxidative/electrophilicstress

(2012) Surendra Singh et al.   FREE RADICAL BIOLOGY AND MEDICINE

Putative Mechanisms of Environmental Chemical–Induced Steatosis

(2012) J. Phillip Kaiser et al.   INTERNATIONAL JOURNAL OF TOXICOLOGY

clusterProfiler: an R Package for Comparing Biological Themes Among Gene Clusters

(2012) Guangchuang Yu et al.   OMICS-A JOURNAL OF INTEGRATIVE BIOLOGY

A 4-Gene Signature Associated with Clinical Outcome in High-Grade Gliomas

(2011) M. de Tayrac et al.   CLINICAL CANCER RESEARCH

Serum Cytokeratin 18 and Cytokine Elevations Suggest A High Prevalence of Occupational Liver Disease in Highly Exposed Elastomer/Polymer Workers

(2011) Matt Cave et al.   JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL MEDICINE

Nonalcoholic Fatty Liver Disease: Pathology and Pathogenesis

(2010) Dina G. Tiniakos et al.   Annual Review of Pathology-Mechanisms of Disease

Activation of the aryl hydrocarbon receptor induces hepatic steatosis via the upregulation of fatty acid transport

(2010) Yuki Kawano et al.   ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS

Adverse outcome pathways: A conceptual framework to support ecotoxicology research and risk assessment

(2010) Gerald T. Ankley et al.   ENVIRONMENTAL TOXICOLOGY AND CHEMISTRY

A Novel Role for the Dioxin Receptor in Fatty Acid Metabolism and Hepatic Steatosis

(2010) Jung Hoon Lee et al.   GASTROENTEROLOGY

Drug-induced toxicity on mitochondria and lipid metabolism: Mechanistic diversity and deleterious consequences for the liver

(2010) Karima Begriche et al.   JOURNAL OF HEPATOLOGY

Anabolic-androgenic steroids: a possible new risk factor of toxicant-associated fatty liver disease

(2010) Paulo Adriano Schwingel et al.   LIVER INTERNATIONAL

Effects of farnesoid X receptor on the expression of the fatty acid synthetase and hepatic lipase

(2010) Li-Li Shen et al.   MOLECULAR BIOLOGY REPORTS

Pioglitazone, Vitamin E, or Placebo for Nonalcoholic Steatohepatitis

(2010) Arun J. Sanyal et al.   NEW ENGLAND JOURNAL OF MEDICINE

Overactivation of the MEK/ERK Pathway in Liver Tumor Cells Confers Resistance to TGF- -Induced Cell Death through Impairing Up-regulation of the NADPH Oxidase NOX4

(2009) L. Caja et al.   CANCER RESEARCH

Toxicant-associated steatohepatitis in vinyl chloride workers

(2009) Matt Cave et al.   HEPATOLOGY

FXR activation reverses insulin resistance and lipid abnormalities and protects against liver steatosis in Zucker (fa/fa) obese rats

(2009) Sabrina Cipriani et al.   JOURNAL OF LIPID RESEARCH

Mapping identifiers for the integration of genomic datasets with the R/Bioconductor package biomaRt

(2009) Steffen Durinck et al.   Nature Protocols

arrayQualityMetrics—a bioconductor package for quality assessment of microarray data

(2008) Audrey Kauffmann et al.   BIOINFORMATICS

Molecular Mechanisms and Therapeutic Targets in Steatosis and Steatohepatitis

(2008) N. Anderson et al.   PHARMACOLOGICAL REVIEWS

Parallelogram Approach Using Rat-Human In Vitro and Rat In Vivo Toxicogenomics Predicts Acetaminophen-induced Hepatotoxicity in Humans

(2008) Anne S. Kienhuis et al.   TOXICOLOGICAL SCIENCES

Hepatic Fatty Acid Transporter Cd36 Is a Common Target of LXR, PXR, and PPARγ in Promoting Steatosis

(2007) Jie Zhou et al.   GASTROENTEROLOGY